Ozari vs Mochi Health: Which Compounded GLP-1 Provider Is Right for You?

Sarah spent three weeks researching telehealth GLP-1 providers before she finally threw up her hands in frustration. "They all say basically the same thing," she told me during her consultation. "Affordable, convenient, quality medications. But what's actually different?" It's a fair question, and one we hear almost daily from patients trying to choose between providers like Ozari and Mochi Health. Both companies offer compounded semaglutide and tirzepatide at prices that won't require a second mortgage. Both promise convenience and clinical oversight. So how do you actually decide?

The truth is, not all compounded GLP-1 providers are created equal. While the marketing might look similar, there are meaningful differences in pricing structure, medication sourcing, compounding pharmacy partnerships, and the level of ongoing support you'll receive. We've seen patients jump from provider to provider, frustrated by hidden costs or lack of responsiveness. Let's break down what actually matters when comparing Ozari to Mochi Health, so you can make an informed decision without the sales pitch.

Pricing and Cost Transparency: What You'll Actually Pay

Let's start with the number that matters most to most people: monthly cost. Ozari's pricing starts at $99 per month for compounded semaglutide, with tirzepatide options also available at competitive rates. There's no signup fee, no hidden consultation charges, and no mandatory add-ons. What you see is what you pay.

Mochi Health's pricing structure is somewhat different. Their advertised rates start around $199 per month for semaglutide, though they do occasionally run promotional pricing that brings costs down. They also offer tirzepatide, typically at higher price points. One thing to watch for: some patients report that the initial quoted price doesn't always include consultation fees or shipping costs, which can add $30-50 to your first order.

Here's where it gets interesting. Both companies adjust dosing as you progress through treatment, which is medically appropriate—you start low and gradually increase to minimize side effects. But the way they handle dose escalation financially differs. At Ozari, the $99 starting price holds steady through your initial dosing phases, and you're clearly informed before any price changes based on higher doses. Some Mochi patients have reported surprise billing when they moved from starter doses to maintenance doses, finding their monthly cost suddenly jumped without clear advance notice.

In our clinical experience, cost predictability matters almost as much as the base price. You're committing to months of treatment—potentially 6-12 months or longer. A provider that starts at $199 but stays consistent might actually cost less than one that starts at $150 but adds fees and increases prices unexpectedly. Always ask about the total cost through a full treatment cycle, not just the first month.

Both providers accept HSA and FSA payments, which is helpful for many patients. Neither currently accepts insurance directly, though both will provide documentation you can submit for potential reimbursement. Don't expect insurance to cover compounded medications, though. We see reimbursement approval rates under 10% for compounded GLP-1s, even with solid documentation.

One cost advantage Ozari offers: if you experience side effects that make the medication intolerable and need to discontinue, there's flexibility in the cancellation policy. You're not locked into long-term contracts. Mochi's cancellation terms are less clearly stated upfront, and some patients report difficulty getting clear answers about stopping treatment or getting refunds for unused medication.

Medication Quality and Compounding Pharmacy Standards

This is where many comparison articles get vague and hand-wavy. Let's be specific. Both Ozari and Mochi Health use compounded versions of semaglutide and tirzepatide, not the brand-name versions (Ozempic, Wegovy, Mounjaro, Zepbound). That's how they can offer these medications at $99-199 instead of $1,000+ per month.

Compounded medications are legal and FDA-regulated, but they're not FDA-approved in the same way brand-name drugs are. The FDA allows compounding pharmacies to create customized versions of medications, particularly during drug shortages. Both semaglutide and tirzepatide have been on the FDA shortage list, which is why compounding has been permitted.

Ozari partners exclusively with 503B compounding facilities. This designation is important. 503B pharmacies are registered outsourcing facilities that meet higher regulatory standards than traditional compounding pharmacies. They're subject to FDA inspection, must follow current good manufacturing practices (cGMP), and submit to more rigorous testing protocols. Every batch is tested for sterility, potency, and purity before it ships.

Mochi Health also claims to work with reputable compounding pharmacies, though their website is less specific about whether these are 503A or 503B facilities. The distinction matters. 503A pharmacies can legally compound medications but aren't held to the same manufacturing standards. They're regulated at the state level, which creates variability. Some 503A facilities are excellent; others have been shut down for contamination or potency issues.

When we review the actual medication vials, Ozari's come with clear batch numbers, expiration dates, and certificates of analysis available upon request. The packaging is professional and includes proper storage instructions. Patient reports about Mochi's packaging are generally positive as well, though we've heard occasional concerns about vials arriving without adequate temperature control during shipping.

Here's what you should ask any compounded GLP-1 provider: What type of compounding pharmacy do you use? Can I see the certificate of analysis for my specific batch? What testing is done before medications ship? How is temperature maintained during shipping? Legitimate providers will answer these questions clearly. Evasive answers are a red flag.

Clinical Support and Ongoing Medical Oversight

Getting the prescription is just the beginning. You're going to have questions. You might experience side effects. Your dose will need adjustment. How the provider handles ongoing care makes a huge difference in your treatment success.

Ozari includes ongoing clinical support as part of the base price. You're not just buying medication; you're getting access to licensed healthcare providers who can answer questions, adjust dosing, and help troubleshoot issues. Most patients hear back within 24 hours on clinical questions, often sooner. There's also a patient support team available for non-medical questions about shipping, billing, or account issues.

The initial consultation at Ozari is conducted by a licensed physician or nurse practitioner who reviews your medical history, current medications, and weight loss goals. They'll screen for contraindications—things like personal history of medullary thyroid cancer, multiple endocrine neoplasia syndrome type 2, or severe gastroparesis that would make GLP-1 therapy unsafe. This isn't just box-checking. We've declined to prescribe for patients when it's not clinically appropriate, even though it means losing a customer.

Mochi Health also provides medical oversight, with an initial consultation required before prescribing. Their providers are licensed and qualified. Where we hear occasional complaints is in response time. Several patients have reported waiting 3-5 days for responses to clinical questions, which can feel like forever when you're experiencing side effects or aren't sure whether to take your next dose. Their customer service for non-medical issues gets mixed reviews—some patients report excellent experiences, others describe difficulties reaching anyone to resolve billing or shipping problems.

One area where Ozari differentiates itself: proactive check-ins. Around week 3-4 of treatment, you'll typically receive outreach asking how you're tolerating the medication and whether you're experiencing any issues. This catches problems early. It's also when dose adjustments are often appropriate, as you've had time to adapt to the initial dose. Mochi's approach appears more reactive—you reach out when you have concerns, rather than receiving proactive check-ins.

Both providers offer the option to pause treatment if needed, which is important. If you get sick, need surgery, or experience side effects that require a break, you shouldn't be forced to continue or lose your spot entirely. The ease of pausing and restarting differs between providers, with Ozari offering clearer guidance on this process upfront.

User Experience: Onboarding, Ordering, and Shipping

The practical stuff matters. How long from signup to receiving your first dose? How easy is the ordering process? Does your medication arrive safely?

Ozari's onboarding typically takes 2-3 days from initial consultation to medication shipped. You complete a medical intake form online, have a brief consultation with a provider (usually via secure messaging, with video calls available if needed), and if approved, your prescription is sent to the compounding pharmacy. Most patients receive their first shipment within 5-7 days of approval.

Mochi Health's timeline is similar—most patients report receiving medication within a week of approval. Their onboarding questionnaire is thorough, covering medical history and current health status. The consultation process is comparable to Ozari's, conducted primarily through their platform with provider review and approval.

Shipping is where we see the most variability across the industry. Ozari ships via temperature-controlled packaging with ice packs and insulation to maintain proper storage conditions. Semaglutide and tirzepatide should be refrigerated, though they can tolerate room temperature for limited periods. The packaging is designed to maintain safe temperatures for 48+ hours in transit.

Mochi also uses insulated shipping, though we've heard occasional reports of medications arriving warm, particularly during summer months or in hot climates. To be fair, this is an industry-wide challenge. If your medication arrives warm to the touch or the ice packs are completely melted, contact the provider immediately. They should replace it at no charge.

Refill reminders and automatic shipments are available with both providers. Ozari sends reminders about a week before you're due to run out and makes reordering simple through their patient portal. Mochi offers similar functionality. Both providers allow you to adjust timing if you need your next shipment earlier or later than scheduled.

One user experience advantage Ozari offers: clearer labeling and instructions. Each vial comes with straightforward guidance on reconstitution (if needed), dosing, and injection technique. There are video tutorials available through the patient portal. Mochi provides instructions as well, though some patients report the information feels scattered across multiple emails rather than consolidated in one easy-to-find location.

From the Ozari Care Team

We tell our patients that choosing a GLP-1 provider is like choosing any healthcare partner—you want someone who'll be there for the long haul, not just take your money and disappear. Look beyond the initial price and evaluate the total package: medication quality, clinical support, communication responsiveness, and transparency about costs. If a provider can't clearly answer questions about their compounding pharmacy standards or dodges questions about ongoing support, that's information in itself. You deserve clear answers and consistent care throughout your weight loss journey.

Key Takeaways

• Ozari starts at $99/month for compounded semaglutide with no hidden fees; Mochi typically starts around $199/month but watch for additional consultation or shipping charges not included in advertised pricing
• Ozari exclusively uses 503B compounding facilities with FDA oversight and cGMP standards; Mochi's compounding pharmacy specifications are less clearly detailed on their platform
• Both providers offer legitimate medical oversight, but Ozari provides more proactive check-ins and faster response times to clinical questions based on patient reports
• Shipping quality and temperature control are comparable between providers, though both can experience occasional issues during extreme weather—always check your medication upon arrival
• Neither provider locks you into long-term contracts, but Ozari's cancellation and pause policies are more clearly communicated upfront with better flexibility for patients who need to stop treatment

Frequently Asked Questions

Is compounded semaglutide from Ozari or Mochi as effective as brand-name Ozempic or Wegovy?

Compounded semaglutide contains the same active ingredient as brand-name versions and works through the same mechanism—it's a GLP-1 receptor agonist that reduces appetite and slows gastric emptying. The STEP 1 trial showed brand-name semaglutide produced average weight loss of 14.9% over 68 weeks, and we see similar results with properly compounded versions in our patient population. The key is ensuring your provider uses a high-quality 503B compounding pharmacy with rigorous testing. Not all compounded medications are equal, which is why pharmacy standards matter so much when choosing a provider.

Can I switch from Mochi to Ozari (or vice versa) if I'm not happy with my current provider?

Yes, you can absolutely switch providers while continuing GLP-1 therapy. You'll need a new consultation and prescription from your new provider, but if you're already taking semaglutide or tirzepatide, they'll typically continue you at your current dose rather than starting over at the lowest dose. Give your new provider details about your current dosing schedule and how you've been tolerating the medication. There might be a brief gap between providers, so plan ahead and don't wait until you're completely out of medication to make the switch. Most patients transition smoothly, though you'll want to watch for any differences in formulation that might affect your tolerance.

What happens if I have side effects? Will Ozari or Mochi help me manage them?

Both providers should help you manage side effects—that's part of appropriate medical oversight. Common GLP-1 side effects include nausea, constipation, diarrhea, and reduced appetite (which is partly how the medication works). Most side effects are dose-dependent and improve with time. Ozari's clinical team can adjust your dose, suggest timing changes for injections, or recommend supportive strategies like anti-nausea medication or dietary modifications. We typically respond to side effect questions within 24 hours, often sooner for concerning symptoms. Mochi offers similar support, though response times may be longer based on patient feedback. Severe side effects like persistent vomiting, severe abdominal pain, or signs of pancreatitis require immediate medical attention—call 911 rather than waiting for your telehealth provider to respond.

Do Ozari and Mochi offer tirzepatide (Mounjaro/Zepbound) or just semaglutide?

Both Ozari and Mochi offer compounded tirzepatide in addition to semaglutide. Tirzepatide is a dual GIP/GLP-1 receptor agonist that showed even greater weight loss than semaglutide in head-to-head studies—the SURMOUNT-1 trial demonstrated average weight loss of 20.9% with the highest dose of tirzepatide over 72 weeks. Some patients tolerate tirzepatide better than semaglutide, while others find the opposite. Pricing for tirzepatide is typically higher than semaglutide at both providers due to the medication's complexity and cost. At Ozari, tirzepatide options are clearly priced in the patient portal. Mochi also offers tirzepatide, though you'll want to confirm exact pricing during your consultation as it can vary.

How do I know if a compounded GLP-1 provider is legitimate and safe?

Look for several key indicators: licensed healthcare providers conducting real medical evaluations (not just automated questionnaires), use of registered 503B compounding facilities, clear information about medication sourcing and testing, professional packaging with batch numbers and expiration dates, and responsive clinical support for questions and concerns. Red flags include providers who'll prescribe to anyone regardless of medical history, unusually low prices that seem too good to be true, inability or unwillingness to provide information about their compounding pharmacy, or lack of licensed medical oversight. Both Ozari and Mochi meet the basic legitimacy standards, though Ozari provides more detailed transparency about pharmacy partnerships and testing protocols. Don't be afraid to ask tough questions—legitimate providers will answer them clearly and thoroughly.

At Ozari Health, we offer compounded Semaglutide and Tirzepatide as low as $99/month, shipped to your door. Learn more at ozarihealth.com.